Response to trastuzumab by HER2 expressing breast tumour xenografts is accompanied by decreased Hexokinase II, glut1 and [18F]-FDG incorporation and changes in 31P-NMR-detectable phosphomonoesters. (2013)
Attributed to:
Development of novel 18F-biotin conjugates for imaging pre-targeted antigens with positron emission tomography (PET)
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00280-012-2032-6
PubMed Identifier: 23178956
Publication URI: http://europepmc.org/abstract/MED/23178956
Type: Journal Article/Review
Volume: 71
Parent Publication: Cancer chemotherapy and pharmacology
Issue: 2
ISSN: 0344-5704